BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 7808021)

  • 1. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
    Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
    Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of early AIDS-related Kaposi's sarcoma with oral all-trans-retinoic acid: results of a sequential non-randomized phase II trial. Kaposi's Sarcoma ANRS Study Group. Agence Nationale de Recherches sur le SIDA.
    Saiag P; Pavlovic M; Clerici T; Feauveau V; Nicolas JC; Emile D; Chastang C
    AIDS; 1998 Nov; 12(16):2169-76. PubMed ID: 9833858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma.
    Bernstein ZP; Chanan-Khan A; Miller KC; Northfelt DW; Lopez-Berestein G; Gill PS
    Cancer; 2002 Dec; 95(12):2555-61. PubMed ID: 12467070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma.
    Tulpule A; Joshi B; DeGuzman N; Espina BM; Mocharnuk R; Prakash O; Templeton D; Levine AM; Gill PS
    Ann Oncol; 1997 Jan; 8(1):79-83. PubMed ID: 9093711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma.
    Miles SA; Dezube BJ; Lee JY; Krown SE; Fletcher MA; Saville MW; Kaplan L; Groopman J; Scadden DT; Cooley T; Von Roenn J; Friedman-Kien A;
    AIDS; 2002 Feb; 16(3):421-9. PubMed ID: 11834954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.
    Gill PS; Mitsuyasu RT; Montgomery T; Huang J; Cabriales S; Testa M; Espina BM; Levine AM; Miles SA
    Cancer J Sci Am; 1997; 3(5):278-83. PubMed ID: 9327151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma.
    Gill PS; Lunardi-Ishkandar Y; Louie S; Tulpule A; Zheng T; Espina BM; Besnier JM; Hermans P; Levine AM; Bryant JL; Gallo RC
    N Engl J Med; 1996 Oct; 335(17):1261-9. PubMed ID: 8857005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
    Cheung TW; Remick SC; Azarnia N; Proper JA; Barrueco JR; Dezube BJ
    Clin Cancer Res; 1999 Nov; 5(11):3432-7. PubMed ID: 10589755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
    Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
    J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057.
    Miles S; Levine A; Feldstein M; Carden J; Cabriallas S; Marcus S; Mitsuyasu R; Gill P
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):17-23. PubMed ID: 9557213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
    Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
    AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [AIDS-associated Kaposi's sarcoma: 22 cases].
    Dhrif AS; Kilani B; Ammari L; Kanoun F; Tiouri H; Ben Chaaben T
    Tunis Med; 2007 Jun; 85(6):494-9. PubMed ID: 17644904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.
    Schwartsmann G; Sprinz E; Kromfield M; Kalakun L; Sander E; Prolla G; Di Leone L; Gerhardt L; Mans DR
    J Clin Oncol; 1997 May; 15(5):2118-24. PubMed ID: 9164226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma.
    Amantea MA; Forrest A; Northfelt DW; Mamelok R
    Clin Pharmacol Ther; 1997 Mar; 61(3):301-11. PubMed ID: 9084455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docetaxel in anthracycline-pretreated AIDS-related Kaposi's sarcoma: a retrospective study.
    Autier J; Picard-Dahan C; Marinho E; Grossin M; Yeni P; Leport C; Vildé JL; Crickx B; Descamps V
    Br J Dermatol; 2005 May; 152(5):1026-9. PubMed ID: 15888164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team.
    Noy A; Scadden DT; Lee J; Dezube BJ; Aboulafia D; Tulpule A; Walmsley S; Gill P
    J Clin Oncol; 2005 Feb; 23(5):990-8. PubMed ID: 15598977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.
    Tulpule A; Groopman J; Saville MW; Harrington W; Friedman-Kien A; Espina BM; Garces C; Mantelle L; Mettinger K; Scadden DT; Gill PS
    Cancer; 2002 Jul; 95(1):147-54. PubMed ID: 12115328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome.
    Shepherd FA; Evans WK; Garvey B; Read SE; Klein M; Fanning MM; Coates R
    CMAJ; 1988 Oct; 139(7):635-9. PubMed ID: 2458177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial.
    Gill PS; Rarick M; McCutchan JA; Slater L; Parker B; Muchmore E; Bernstein-Singer M; Akil B; Espina BM; Krailo M
    Am J Med; 1991 Apr; 90(4):427-33. PubMed ID: 1707230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
    Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
    J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.